Unknown

Dataset Information

0

Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.

ABSTRACT: The association between epidermal growth factor (EGF) gene +61A/G polymorphism (rs4444903) and hepatocellular carcinoma (HCC) susceptibility has been widely reported, but the results were inconsistent. To clarify the effect of this polymorphism on HCC risk, a meta-analysis was performed.The PubMed, Embase, Cochrane Library, Web of Science, Chinese BioMedical Literature (CBM), Wanfang and Chinese National Knowledge Infrastructure (CNKI) databases were systematically searched to identify relevant studies published up to December 2013. Data were extracted independently by two authors. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to assess the strength of association.A total of 16 studies including 2475 HCC cases and 5381 controls were included in this meta-analysis. Overall, a significantly increased HCC risk was observed under all genetic models (G vs. A: OR?=?1.383, P?

SUBMITTER: Jiang G 

PROVIDER: S-EPMC4418097 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.

Jiang Guoping G   Yu Ke K   Shao Lifang L   Yu Xiaobo X   Hu Chen C   Qian Pei P   Xie Haiyang H   Li Jinjun J   Zheng Jie J   Zheng Shusen S  

BMC cancer 20150425

<h4>Background</h4>The association between epidermal growth factor (EGF) gene +61A/G polymorphism (rs4444903) and hepatocellular carcinoma (HCC) susceptibility has been widely reported, but the results were inconsistent. To clarify the effect of this polymorphism on HCC risk, a meta-analysis was performed.<h4>Methods</h4>The PubMed, Embase, Cochrane Library, Web of Science, Chinese BioMedical Literature (CBM), Wanfang and Chinese National Knowledge Infrastructure (CNKI) databases were systematic  ...[more]

Similar Datasets

Unknown Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
| S-EPMC3438803 | biostudies-literature
Unknown Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population.
| S-EPMC5758736 | biostudies-literature
Unknown Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.
| S-EPMC4665625 | biostudies-literature
Unknown Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
| S-EPMC3293888 | biostudies-literature
Unknown A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
| S-EPMC3129453 | biostudies-literature
Unknown A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients.
| S-EPMC3865974 | biostudies-literature
Unknown Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
| S-EPMC7573408 | biostudies-literature
Unknown Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
| S-EPMC3621500 | biostudies-literature
Unknown Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.
| S-EPMC4300692 | biostudies-literature
Unknown Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
| S-EPMC4086837 | biostudies-literature